Recorded live at the 2019 San Antonio Breast Cancer Symposium, Dr. Matt Birnholz sat down with Dr. Nadine Tung, Associate Professor of Medicine at Harvard Medical School and Director of the Cancer Risk and Prevention Program at Beth Israel Deaconess Medical Center, to talk about her presentation on genetic testing for hereditary breast cancer.

Ms. Marina Kaplan's inspiring life history as an "outlier survivor" as she put it for having achieved remission from triple-negative breast cancer over six years ago was helped by numerous cutting-edge clinical trials made accessible to her. But the experience as a study subject exposed her to systemic barriers confronting breast cancer patients everywhere, compelling her to reprise her epidemiology career expertise in conducting a study looking for novel solutions, as she shares with Dr. Matt Birnholz at the 2019 San Antonio Breast Cancer Symposium.

To learn more about the effects of dietary interventions after early breast cancer treatment and the current gaps that exist in systemic reviews that assess those effects, Dr. Matt Birnholz sat down with Dr. Daniela Rosa at the 2019 San Antonio Breast Cancer Symposium.

Much of the focus on endocrine therapy tends to be around future directions and what new treatments are going to accelerate care for breast cancer patients. But oncologists need to take stock of how physically and financially costly it can be, as Dr. Dawn Hershman explains to Dr. Matt Birnholz at the 2019 San Antonio Breast Cancer Symposium.

Vaccine hesitancy refers to a delay in acceptance or refusal of vaccines, despite their availability and an overall recommendation for them. To help reinforce the importance of vaccinations, this activity describes the threat vaccine hesitancy poses to public health and the relationship between HPV vaccination and protection from cervical and oropharyngeal cancers.

Tune in as Dr. Jen Simmons is joined by Dr. Susan Domcheck, who debunks the common misconception that men don’t have to worry about the BCRA mutation and dives into the explorations of the Before Study.

Anytime the topic of genetic testing comes up in the context of breast and ovarian cancers, one question that undoubtedly arises is: who exactly should be tested? That’s the FAQ Dr. Susan Domchek, Director of the McDonald Women’s Cancer Risk Evaluation Center at the Hospital of the University of Pennsylvania, answers.

Tune in as Dr. Matt Birnholz talks with Thanos Kosmidis, the founder and CEO of Care Across, about the company’s new poster presentation on breast cancer patients’ quality of life at the 2019 European Society for Medical Oncology (ESMO) Congress in Barcelona, Spain.

Learn more about the mission of the Lurie Cancer Center’s Lynn Sage Breast Cancer Symposium and the topics featured at the 2019 conference from Dr. William Gradishar, who’s served as the Chair of the Lynn Sage Breast Cancer Symposium since its inception in 1998.

Tune in to hear Dr. William Gradishar break down his presentations as well as other highlights attendees can look forward to at the 2019 Lynn Sage Breast Cancer Symposium in Chicago, Illinois.